Sangamo Therapeutics Inc – Strategy, SWOT and Corporate Finance Report

Sangamo Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding protein Zinc Finger Transcription (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its product candidates targets the treatment of HIV/AIDS, hemophilia A and B, hurler syndrome (MPS I), fabry disease, Huntington's disease and many others. Its ZFPs based products are used in various applications such as human therapeutics, research reagents, pharmaceutical protein production, plant agriculture, cell-line engineering and production of transgenic animals. Sangamo is headquartered in Richmond, California, the US.

Scope

Detailed information on Sangamo Therapeutics Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Sangamo Therapeutics Inc in the form of a SWOT analysis

An in-depth view of the business model of Sangamo Therapeutics Inc including a breakdown and examination of key business segments

News about Sangamo Therapeutics Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Sangamo Therapeutics Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Sangamo Therapeutics Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Sangamo Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Precision Biosciences Inc

Pfizer Inc

Novo Nordisk Inc

Novartis Corp

Merck & Co Inc

GlaxoSmithKline Plc

Genzyme Corp

Genentech Inc

Editas Medicine Inc

BioMarin Pharmaceutical Inc

Beam Therapeutics Inc

Amgen Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sangamo Therapeutics Inc - Key Facts

Sangamo Therapeutics Inc - Key Employees

Sangamo Therapeutics Inc - Key Employee Biographies

Sangamo Therapeutics Inc - Major Products and Services

Sangamo Therapeutics Inc - History

Sangamo Therapeutics Inc - Company Statement

Sangamo Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Sangamo Therapeutics Inc - Business Description

Sangamo Therapeutics Inc - Corporate Strategy

Sangamo Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Sangamo Therapeutics Inc - Strengths

Sangamo Therapeutics Inc - Weaknesses

Sangamo Therapeutics Inc - Opportunities

Sangamo Therapeutics Inc - Threats

Sangamo Therapeutics Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sangamo Therapeutics Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

May 08, 2019: Sangamo Therapeutics reports first quarter 2019 financial results

Apr 15, 2019: Sangamo Therapeutics announces presentations at 2019 Annual Meeting Of The American Society Of Gene & Cell Therapy

Apr 02, 2019: Sangamo announces agreement securing access to large-scale, commercial-grade manufacturing capacity At Brammer Bio

Mar 12, 2019: Sangamo Therapeutics names Jason Fontenot, Ph.D., as Senior Vice President, cell therapy

Mar 08, 2019: Sangamo Therapeutics announces publication of data demonstrating new Zinc Finger Nuclease architectures enabling high-precision genome editing

Feb 28, 2019: Sangamo Therapeutics reports fourth quarter and full year 2018 financial results

Jan 22, 2019: Sangamo Therapeutics names Adrian Woolfson, BM., B.Ch., Ph.D., as Executive Vice President of Research and Development

Nov 08, 2018: Sangamo Therapeutics reports third quarter 2018 financial results

Aug 23, 2018: SEC Charges Former Pharma Executive and Others with Insider Trading

Aug 08, 2018: Sangamo Therapeutics reports second quarter 2018 financial results

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Sangamo Therapeutics Inc, Key Facts

Sangamo Therapeutics Inc, Key Employees

Sangamo Therapeutics Inc, Key Employee Biographies

Sangamo Therapeutics Inc, Major Products and Services

Sangamo Therapeutics Inc, History

Sangamo Therapeutics Inc, Subsidiaries

Sangamo Therapeutics Inc, Key Competitors

Sangamo Therapeutics Inc, Ratios based on current share price

Sangamo Therapeutics Inc, Annual Ratios

Sangamo Therapeutics Inc, Annual Ratios (Cont…1)

Sangamo Therapeutics Inc, Interim Ratios

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sangamo Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sangamo Therapeutics Inc, Performance Chart (2014 – 2018)

Sangamo Therapeutics Inc, Ratio Charts

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports